We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
A urine-based ELISA with recombinant non-glycosylated SARS-CoV-2 spike protein for detecting anti-SARS-CoV-2 spike antibodies.
- Authors
Ramos, Fernanda F.; Bagno, Flávia F.; Vassallo, Paula F.; Oliveira-da-Silva, João A.; Reis, Thiago A. R.; Bandeira, Raquel S.; Machado, Amanda S.; Lage, Daniela P.; Martins, Vivian T.; Fernandes, Ana P.; Christodoulides, Myron; Ravetti, Cecilia G.; Nobre, Vandack; da Fonseca, Flávio G.; Coelho, Eduardo A. F.; Ludolf, Fernanda
- Abstract
Serological assays have been widely used to detect anti-SARS-CoV-2 antibodies, which are generated from previous exposure to the virus or after vaccination. The presence of anti-SARS-CoV-2 Nucleocapsid antibodies was recently reported in patients´ urine using an in-house urine-based ELISA-platform, allowing a non-invasive way to collect clinical samples and assess immune conversion. In the current study, we evaluated and validated another in-house urine-based ELISA for the detection of anti-SARS-CoV-2 Spike antibodies. Three partial recombinant SARS-CoV-2 Spike proteins comprising the Receptor Binding Domain, expressed in eukaryotic or prokaryotic systems, were tested in an ELISA platform against a panel of over 140 urine and paired serum samples collected from 106 patients confirmed positive for SARS-CoV-2 by qRT-PCR. The key findings from our study were that anti-SARS-CoV-2 Spike antibodies could be detected in urine samples and that the prokaryotic expression of the rSARS-CoV-2 Spike protein was not a barrier to obtain relatively high serology efficiency for the urine-based assay. Thus, use of a urine-based ELISA assay with partial rSARS-CoV-2 Spike proteins, expressed in a prokaryotic system, could be considered as a convenient tool for screening for the presence of anti-SARS-CoV-2 Spike antibodies, and overcome the difficulties arising from sample collection and the need for recombinant proteins produced with eukaryotic expression systems.
- Subjects
IMMUNOGLOBULINS; RECOMBINANT proteins; SARS-CoV-2; PROTEINS; PROTEIN receptors; URINE
- Publication
Scientific Reports, 2023, Vol 13, Issue 1, p1
- ISSN
2045-2322
- Publication type
Article
- DOI
10.1038/s41598-023-31382-5